Health
Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study – PharmiWeb.com
New preventative nasal spray treatment that could protect people from COVID-19 infection and prevent transmission announced Novel therapy developed by Australian biotech company, Ena Respiratory, shown to significantly reduce COVID-19 virus levels in the nose…
- New preventative nasal spray treatment that could protect people from COVID-19 infection and prevent transmission announced
- Novel therapy developed by Australian biotech company, Ena Respiratory, shown to significantly reduce COVID-19 virus levels in the nose and throat, in a gold-standard animal study
- Reduced COVID-19 replication by up to 96%, study performed by Public Health England (PHE) scientists
- Mode of action complementary to COVID-19 vaccines, with easy n…
Continue Reading
-
Noosa News22 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News21 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Business8 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General17 hours ago‘Potential’ hacker contacts Qantas over data breach